Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Montes

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Pathologica|July 21, 2000
Effects of oral contraceptives in vaginal cytologyM B Montes, A C Ferreira, J C Fenólio, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapyM N Rousseau, L Vergne, B Montes, et al.
Journal of Medical Virology|December 1, 1996
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasmaJ Coste, B Montes, J Reynes, et al.
Journal of Surgical Oncology|September 28, 2018
Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective studyJavier Suárez, Andrea Goicoetxea, M L Gómez, et al.
Journal of Biophotonics|January 10, 2018
Light sheet microscopy and SrAl<sub>2</sub> O<sub>4</sub> nanoparticles codoped with Eu<sup>2+</sup> /Dy<sup>3+</sup> ions for cancer cell taggingBonifacio Can-Uc, Juana B Montes-Frausto, Karla Juarez-Moreno, et al.
AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyM Segondy, J Izopet, I Pellegrin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2001
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapyI Pellegrin, M Segondy, I Garrigue, et al.
Cellular Signalling|October 10, 2022
ERK activation modulates invasiveness and Reactive Oxygen Species (ROS) production in triple negative breast cancer cell linesAdilene Acosta-Casique, José B Montes-Alvarado, Minuet Barragán, et al.
Glycobiology|January 8, 2010
Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscleMarcelo Dias-Baruffi, Sean R Stowell, Shuh-Chyung Song, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pathologica|July 21, 2000
Effects of oral contraceptives in vaginal cytologyM B Montes, A C Ferreira, J C Fenólio, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2001
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapyM N Rousseau, L Vergne, B Montes, et al.
Journal of Medical Virology|December 1, 1996
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasmaJ Coste, B Montes, J Reynes, et al.
Journal of Surgical Oncology|September 28, 2018
Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective studyJavier Suárez, Andrea Goicoetxea, M L Gómez, et al.
Journal of Biophotonics|January 10, 2018
Light sheet microscopy and SrAl<sub>2</sub> O<sub>4</sub> nanoparticles codoped with Eu<sup>2+</sup> /Dy<sup>3+</sup> ions for cancer cell taggingBonifacio Can-Uc, Juana B Montes-Frausto, Karla Juarez-Moreno, et al.
AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyM Segondy, J Izopet, I Pellegrin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2001
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapyI Pellegrin, M Segondy, I Garrigue, et al.
Cellular Signalling|October 10, 2022
ERK activation modulates invasiveness and Reactive Oxygen Species (ROS) production in triple negative breast cancer cell linesAdilene Acosta-Casique, José B Montes-Alvarado, Minuet Barragán, et al.
Glycobiology|January 8, 2010
Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscleMarcelo Dias-Baruffi, Sean R Stowell, Shuh-Chyung Song, et al.
Pageof 4